# Irinotecan and Capecitabine in Treating Patients With Solid Tumors

> **NCT00003867** · PHASE1 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** irinotecan hydrochloride

## Key facts

- **NCT ID:** NCT00003867
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03
- **Primary completion:** 2003-03
- **Final completion:** 2003-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003867, "Irinotecan and Capecitabine in Treating Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*